Pediatric Asthma

Primary Care - Clinics in Office Practice

Volumn 35, Issue 1, 2008, Pages 25-40

  Stewart, Lora J ^a  

^a Premier Allergy and Asthma   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIFUNGAL AGENT; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ANTAGONIST; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEXAMETHASONE; FLUNISOLIDE; FLUORINATED HYDROCARBON; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; FORMOTEROL FUMARATE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVALBUTEROL; METHYLPREDNISOLONE; MOMETASONE FUROATE; MONTELUKAST; NEDOCROMIL; OMALIZUMAB; PREDNISONE; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE; TRIAMCINALONE ACETONIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZILEUTON;

ADRENAL SUPPRESSION; ANAMNESIS; ANAPHYLAXIS; ASTHMA; ATOPY; BONE DENSITY; CLINICAL TRIAL; COUGHING; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG DOSE TITRATION; DRUG MEGADOSE; DYSPHONIA; GROWTH INHIBITION; HOARSENESS; HUMAN; LOW DRUG DOSE; MONOTHERAPY; MYOPATHY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; THRUSH; VIRUS INFECTION; WEIGHT GAIN;

ACUTE DISEASE; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; HUMANS; INFANT; INFANT, NEWBORN; RISK FACTORS;

EID: 38149111308     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2007.09.007     Document Type: Review

References (44)

1. Bloom B., Dey A.N., and Freeman G. Summary health statistics for U.S. children: national health interview survey, 2005. National Center for Health Statistics. Vital Health Stat 10 231 (2006) 1-83
2. Centers for Disease Control and Prevention. Morbidity Mortality Weekly Reports. MMWR 55 7 (2006) 185
3. Taussig L.M., Wright A.L., Holberg C.J., et al. Tucson children's respiratory study: 1980 to present. J Allergy Clin Immunol 111 (2003) 661-675
4. Sears M.R., Greene J.M., Willan A.R., et al. A longitudinal, population-based cohort study of childhood asthma followed to adulthood. N Engl J Med 349 (2003) 1414-1422
5. Guilbert T.W., Morgan W.J., Zeiger R.S., et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 354 (2006) 1985-1997
6. Sigurs N., Gustafsson P.M., Bjarnason R., et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 171 (2005) 137-141
7. Lemanske R.F. Viral infections and asthma inception. J Allergy Clin Immunol 114 (2004) 1023-1026
8. Wark P.A., Johnston S.L., Bucchieri F., et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201 (2005) 937-947
9. Hesselmar B., Aberg N., Aberg B., et al. Does early exposure to cat or dog protect against later allergy development?. Clin Exp Allergy 29 (1999) 611-617
10. Braun-Fahrander C., Reidler J., Herz U., et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 347 (2002) 869-877
11. Ernst P., and Cormier Y. Relative scarcity of asthma and atopy among adolescents raised on a farm. Am J Respir Crit Care Med 161 (2000) 1563-1566
12. Rosenstreich D.L., Eggleston P., Kattan M., et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med 336 (1997) 1356-1363
13. Ligonjua A.A., Carey V.J., Burge H.A., et al. Exposure to cockroach allergen in the home is associated with incident doctor-diagnosed asthma and recurrent wheezing. J Allergy Clin Immunol 107 (2001) 41-47
14. Eggleston P.A., Rosenstreich D., Lynn H., et al. Relationship of indoor allergen exposure to skin test sensitivity in inner-city children with asthma. J Allergy Clin Immunol 102 (1998) 563-570
15. Halonen M., Stern D.A., Wright A.L., et al. Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med 155 (1997) 1356-1361
16. Saglani K., Malmstrom A.S., Pelkonen L.P., et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 171 (2005) 722-727
17. Krawiec M.E., Westcott J.Y., Chu H.W., et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. Am J Respir Crit Care Med 163 (2001) 1338-1343
18. Le Bourgeois M., Goncalves M., Le Clainche L., et al. Bronchoalveolar cells in children <3 years old with severe recurrent wheezing. Chest 122 (2002) 761-763
19. Covar R.A., Spahn J.D., Murphy J.R., et al. Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med 170 (2004) 234-241
20. Crapo R.O., Casaburi R., Coates A.L., et al. Guidelines for methacholine and exercise challenge testing 1999. Am J Respir Crit Care Med 161 (2000) 309-329
21. Castro-Rodriguez J.A., Holberg C.J., Wright A.L., et al. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 162 (2000) 1403-1406
22. Guilbert T.W., Morgan W.J., Zeiger R.S., et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol 114 (2004) 1282-1287
23. Moller C., Dreborg S., Ferdousi H.A., et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 109 (2002) 251-256
24. National Institutes of Health. Expert panel report 2: guidelines for the diagnosis and management of asthma, June 2002. Available at: www.nhlbi.nih.gov/guidelines. Accessed December 14, 2007.
25. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 343 (2000) 1054-1063
26. Bateman E.D., Boushey H.A., Bousquet J., et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med 170 (2004) 836-844
27. Simons F.E.R. A comparison of beclomethasone, salmeterol and placebo in children with asthma. N Engl J Med 337 (1997) 1659-1665
28. Agertoft L., and Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 343 (2000) 1064-29
29. Allen D.B. Inhaled steroids for children: effects on growth, bone and adrenal function. Endocrinol Metab Clin North Am 34 (2005) 555-564
30. Zeiger R.S., Szefler S.J., Phillips B.R., et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 117 (2006) 45-52
31. Lazarus S.C., Boushey H.A., Fahy J.V., et al. Long-Acting [beta] 2-agonist monotherapy vs continues therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. J Am Med Assoc 285 (2001) 2583-2593
32. Lemanske Jr. R.F., Sorkness C.A., Mauger E.A., et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. J Am Med Assoc 285 (2001) 2594-2603
33. Nelson H.S., Weiss S.T., Bleecker E.R., et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129 (2006) 15-26
34. Sorkness C.A., Lemanske Jr. R.F., Mauger D.T., et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 119 (2007) 64-72
35. Busse W., Corren J., Lanier B.Q., et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 108 (2001) 184-190
36. Waldeck B. Enantiomers of bronchodilating B2-adrenoceptor agonists: Is there a cause for concern?. J Allergy Clin Immunol 103 (1999) 742-748
37. Nelson HS, Bensch G, Pleskow WW, et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. 1999;102:943-52.
38. Pearlman D.S., van Adelsberg J., Philip G., et al. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Ann Allergy Asthma Immunol 97 (2006) 98-104
39. Cates C.J., Crilly J.A., and Rowe B.H. Holding chambers versus nebulizers for beta-agonist treatment of acute asthma. Cochrane Database Sys Rev 2 (2006) CD000052
40. Qureshis F., Zartisky A., and Lakkis H. Efficacy of ipratropium in severely asthmatic children. Ann Emerg Med 29 (1997) 205-211
41. Afilalo M., Guttman A., Colacone A., et al. Efficacy of inhaled steroids (beclomethasone dipropionate) for treatment of mild to moderately severe asthma in the emergency department: a randomized clinical trial. Ann Emerg Med 33 (1999) 304-309
42. Nakanishi A.K., Klasner A.K., and Rubin B.K. A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. Chest 124 (2003) 790-794
43. Harrison T.W., Oborne J., Newton S., et al. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomized controlled trial. Lancet 363 (2004) 271-275
44. Gibson P.G., Powell H., Coughlan J., et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 1 (2004) CD001117